查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1974051

非侵入性通氣（NIV）市場分析及預測（至2035年）：按類型、產品類型、應用、最終用戶、技術、組件、設備、模式、安裝類型、功能分類

Noninvasive Ventilation (NIV) Market Analysis and Forecast to 2035: Type, Product, Application, End User, Technology, Component, Device, Mode, Installation Type, Functionality
出版日期: | 出版商: Global Insight Services | 英文 309 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

非侵入性通氣（NIV）市場預計將從2024年的32億美元成長到2034年的59億美元，複合年成長率約為5.8%。非侵入性通氣（NIV）市場涵蓋使用面罩或類似介面提供呼吸支援的設備和裝置，無需插管。推動市場成長的因素包括慢性呼吸系統疾病的增加、技術的進步以及人們對居家醫療日益成長的偏好。主要趨勢包括將智慧技術應用於監測以及開發攜帶式、患者友善的設備，這些設備都符合市場對有效、微創呼吸護理解決方案日益成長的需求。

受呼吸系統疾病發病率上升和醫療技術進步的推動，非侵入性通氣 (NIV) 市場正經歷強勁成長。其中，介面（尤其是面罩）是成長最快的細分市場，因為它們在維持患者舒適度和依從性方面發揮著至關重要的作用。人工呼吸器（尤其是攜帶式呼吸機）緊隨其後，反映了居家醫療和患者活動能力的提升。兒童應用領域的重要性日益凸顯，滿足了患有呼吸系統疾病的兒童患者的獨特需求。由於人口老化以及慢性阻塞性肺病(COPD) 和睡眠呼吸中止症的發生率不斷上升，成人市場仍佔據重要地位。通氣模式和監測系統的技術創新正在提升 NIV 解決方案的有效性和安全性。雖然醫院終端用戶市場主導，但成本效益和患者偏好正在推動 NIV 在居家醫療領域的應用日益普及。製造商和醫療保健提供者之間的策略聯盟正在推動市場擴張，並確保在各種醫療保健環境中都能獲得先進的 NIV 解決方案。

市場區隔
類型 持續性呼吸道正壓通氣（CPAP）、雙水平氣道正壓通氣（BiPAP）、自適應伺服通氣、容量保證正壓支持
產品 人工呼吸器、口罩、加濕器和配件
適應症 慢性阻塞性肺病（COPD）、氣喘、睡眠呼吸中止症、急性呼吸衰竭、肺炎、心源性肺水腫、神經肌肉疾病
最終用戶 醫院、居家醫療機構、門診中心、急診中心和長期照護機構
科技 機械通風、智慧通風、可攜式通風、穿戴式通風
成分 鼓風機、管子、面罩、加濕器、過濾器
裝置 全面罩、鼻罩、鼻枕罩、口鼻罩
模式 自主呼吸模式、定時模式、自主呼吸/定時模式
安裝類型 固定式、可攜式
功能 侵入性、非侵入性

市場概況：

非侵入性通氣 (NIV) 市場正經歷著動態變化，創新的定價策略和先進的產品推出推動了市場佔有率的成長。這一演變是由對非侵入性呼吸支持解決方案日益成長的需求所驅動，尤其是在重症監護領域。領先的製造商正在迅速推出滿足醫護人員和患者需求的新型設備，以提高患者的舒適度和易用性。策略聯盟和合作正在推動創新並擴展產品系列，進一步加劇競爭格局。在這個競爭激烈的市場中，各家公司都在努力調整產品以適應日益嚴格的監管標準。監管的影響，尤其是在北美和歐洲，正在塑造產品開發和打入市場策略。主要企業正在加大研發投入，以在遵守這些法規的同時保持競爭優勢。該市場的特點是競爭激烈，瑞思邁 (ResMed)、飛利浦醫療保健 (Philips Healthcare) 和費雪派克醫療保健 (Fisher & Paykel Healthcare) 等主要參與者正在爭奪主導。這些公司正在利用先進技術和策略聯盟來鞏固其市場地位並推動成長。

主要趨勢和促進因素：

由於呼吸系統疾病的日益普遍，非侵入性通氣（NIV）市場正經歷強勁成長。人們對非侵入性通氣相對於有創通氣技術的優勢認知不斷提高，推動了市場擴張。關鍵趨勢包括設備便攜性和易用性的提升，從而提高了患者的舒適度和依從性。新冠疫情加速了NIV的普及，因為醫療機構正在尋求無需插管的有效呼吸支持解決方案。此外，整合監測系統等技術創新正在改善患者預後並提高護理效率。全球人口老化，導致慢性呼吸系統疾病風險增加，是推動市場發展的關鍵因素。此外，新興經濟體醫療基礎設施的改善也促進了NIV技術的普及。投資研發並創造具成本效益創新解決方案的公司擁有眾多機會。持續專注於降低醫療成本和提高病患生活品質，為NIV市場的持續成長和創新奠定了基礎。

限制與挑戰：

非侵入性通氣（NIV）市場面臨許多重大限制與挑戰。其中一個關鍵挑戰是先進NIV設備高成本，限制了低收入地區和小規模醫療機構的取得。這種經濟障礙往往迫使他們依賴療效較差的替代方案，導致患者照護品質下降。此外，缺乏接受過NIV技術訓練的熟練醫護人員也限制了其廣泛應用。缺乏普及的培訓項目可能導致這些設備利用率低甚至誤用。另外，監管的複雜性和各國標準的差異也使得新進業者難以進入市場。另一個挑戰是醫護人員和病患對NIV益處的認知度較低，減緩了NIV的普及速度。最後，科技的快速發展需要不斷更新和升級，這增加了醫療機構的成本。所有這些因素共同構成了NIV市場成長和擴張的重大挑戰。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 持續性呼吸道正壓通氣（CPAP）
    • 雙水平正壓通氣（BiPAP）
    • 自適應伺服通風
    • 容量保證正壓通氣
  • 市場規模及預測：依產品分類
    • 人工呼吸器
    • 面具
    • 加濕器
    • 配件
  • 市場規模及預測：依應用領域分類
    • 慢性阻塞性肺病（COPD）
    • 氣喘
    • 睡眠呼吸中止症
    • 急性呼吸衰竭
    • 肺炎
    • 心源性肺水腫
    • 神經肌肉疾病
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 居家醫療
    • 門診治療中心
    • 急診中心
    • 長期照護機構
  • 市場規模及預測：依技術分類
    • 人工呼吸器
    • 智慧通風
    • 攜帶式人工呼吸器
    • 穿戴式呼吸機
  • 市場規模及預測：依組件分類
    • 鼓風機
    • 管子
    • 面具
    • 加濕器
    • 篩選
  • 市場規模及預測：依設備分類
    • 全臉面罩
    • 鼻罩
    • 鼻枕面罩
    • 口罩
  • 市場規模及預測：按模式
    • 自主呼吸
    • 預定儀式
    • 自主呼吸/定時呼吸
  • 市場規模及預測：依安裝類型分類
    • 固定的
    • 可攜式的
  • 市場規模及預測：依功能分類
    • 侵入性
    • 非侵入性

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • ResMed
  • Fisher Paykel Healthcare
  • Vyaire Medical
  • BMC Medical
  • Drive DeVilbiss Healthcare
  • Hamilton Medical
  • Air Liquide Medical Systems
  • Weinmann Emergency Medical Technology
  • Medtronic
  • Mindray
  • O-Two Medical Technologies
  • Armstrong Medical
  • Seoil Pacific
  • Heyer Medical
  • Siare Engineering International Group

第9章：關於我們

簡介目錄
Product Code: GIS34092

Noninvasive Ventilation (NIV) Market is anticipated to expand from $3.2 billion in 2024 to $5.9billion by 2034, growing at a CAGR of approximately 5.8%. The Noninvasive Ventilation (NIV) Market encompasses devices and equipment that provide respiratory support without the need for intubation, utilizing masks or similar interfaces. This market is driven by rising incidences of chronic respiratory diseases, technological advancements, and an increasing preference for home healthcare. Key trends include the integration of smart technologies for monitoring and the development of portable, patient-friendly devices, aligning with the growing demand for effective and less intrusive respiratory care solutions.

The Noninvasive Ventilation (NIV) Market is experiencing robust growth, fueled by increasing prevalence of respiratory disorders and advancements in medical technology. The interface segment, particularly masks, is the top-performing sub-segment, driven by their essential role in patient comfort and compliance. Ventilators, especially portable models, follow closely, reflecting a shift towards home healthcare and patient mobility. The pediatric application segment is gaining prominence, addressing the unique needs of younger patients with respiratory conditions. The adult segment remains significant, driven by the aging population and rising cases of chronic obstructive pulmonary disease (COPD) and sleep apnea. Technological innovations in ventilation modes and monitoring systems are enhancing the efficacy and safety of NIV solutions. The hospital end-user segment leads, but home care settings are increasingly adopting NIV due to cost-effectiveness and patient preference. Strategic collaborations between manufacturers and healthcare providers are fostering market expansion, ensuring access to advanced NIV solutions across diverse healthcare settings.

Market Segmentation
TypeContinuous Positive Airway Pressure (CPAP), Bi-level Positive Airway Pressure (BiPAP), Adaptive Servo-Ventilation, Volume Assured Pressure Support
ProductVentilators, Masks, Humidifiers, Accessories
ApplicationChronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Acute Respiratory Failure, Pneumonia, Cardiogenic Pulmonary Edema, Neuromuscular Disorders
End UserHospitals, Home Healthcare, Ambulatory Care Centers, Emergency Centers, Long-term Care Facilities
TechnologyMechanical Ventilation, Intelligent Ventilation, Portable Ventilation, Wearable Ventilation
ComponentBlower, Tubing, Mask, Humidifier, Filter
DeviceFull Face Masks, Nasal Masks, Nasal Pillow Masks, Oral Masks
ModeSpontaneous, Timed, Spontaneous/Timed
Installation TypeFixed, Portable
FunctionalityInvasive, Noninvasive

Market Snapshot:

The Noninvasive Ventilation (NIV) market is witnessing a dynamic shift with a growing market share attributed to innovative pricing strategies and the introduction of advanced products. This evolution is driven by heightened demand for noninvasive respiratory support solutions, particularly in critical care settings. Prominent manufacturers are launching new devices that offer enhanced patient comfort and ease of use, meeting the needs of both healthcare providers and patients. The market's competitive landscape is further enriched by strategic partnerships and collaborations, which are fostering innovation and expanding product portfolios. In the competitive arena, companies are benchmarking their offerings against emerging regulatory standards that are increasingly stringent. Regulatory influences, particularly in North America and Europe, are shaping product development and market entry strategies. Key players are investing in research and development to comply with these regulations while maintaining a competitive edge. The market is characterized by robust competition, with leading firms such as ResMed, Philips Healthcare, and Fisher & Paykel Healthcare vying for dominance. These companies are leveraging advanced technologies and strategic alliances to enhance their market positions and drive growth.

Geographical Overview:

The Noninvasive Ventilation (NIV) Market is witnessing substantial expansion across diverse regions, each exhibiting unique growth dynamics. North America remains at the forefront, propelled by advanced healthcare infrastructure and a growing emphasis on patient comfort. The region's commitment to technological innovation and favorable reimbursement policies further bolster market growth. Europe follows with strong healthcare systems and increasing awareness regarding noninvasive solutions, enhancing market penetration. In Asia Pacific, the market is burgeoning, driven by rising healthcare expenditure and a growing prevalence of respiratory disorders. The region's expanding middle class and increasing urbanization are pivotal in accelerating demand for NIV technologies. Latin America is emerging as a promising market, with improving healthcare systems and growing investments in medical technology. Meanwhile, the Middle East & Africa are recognizing the potential of NIV solutions, with increased government initiatives aimed at enhancing healthcare accessibility and quality, thereby unlocking new growth opportunities in these regions.

Key Trends and Drivers:

The Noninvasive Ventilation (NIV) market is experiencing robust growth due to the rising prevalence of respiratory diseases. Increasing awareness of the benefits of noninvasive ventilation over invasive methods is driving market expansion. Key trends include advancements in portable and user-friendly devices, enhancing patient comfort and compliance. The COVID-19 pandemic has accelerated the adoption of NIV, as healthcare providers seek effective respiratory support solutions without intubation. Furthermore, technological innovations such as integrated monitoring systems are improving patient outcomes and care efficiency. The aging global population, with its higher susceptibility to chronic respiratory conditions, is a significant market driver. Additionally, healthcare infrastructure improvements in emerging economies are expanding access to NIV technologies. Opportunities abound for companies investing in research and development to create cost-effective and innovative solutions. With the ongoing focus on reducing healthcare costs and improving patient quality of life, the NIV market is poised for sustained growth and innovation.

Restraints and Challenges:

The Noninvasive Ventilation (NIV) Market faces several significant restraints and challenges. A primary challenge is the high cost of advanced NIV devices, which restricts accessibility in low-income regions and smaller healthcare facilities. This financial barrier often forces reliance on less effective alternatives, compromising patient care. Additionally, the lack of skilled healthcare professionals trained in the use of NIV technology limits its adoption. Training programs are insufficiently widespread, leading to underutilization and potential misuse of these devices. Moreover, regulatory complexities and varying standards across different countries complicate market entry for new players. The market also grapples with issues of limited awareness about the benefits of NIV among healthcare providers and patients, which slows adoption rates. Lastly, the rapid pace of technological advancements necessitates continuous updates and upgrades, imposing additional costs on healthcare institutions. These factors collectively pose substantial challenges to the growth and expansion of the NIV market.

Key Players:

ResMed, Fisher Paykel Healthcare, Vyaire Medical, BMC Medical, Drive DeVilbiss Healthcare, Hamilton Medical, Air Liquide Medical Systems, Weinmann Emergency Medical Technology, Medtronic, Mindray, O-Two Medical Technologies, Armstrong Medical, Seoil Pacific, Heyer Medical, Siare Engineering International Group

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by End User
  • 2.5 Key Market Highlights by Technology
  • 2.6 Key Market Highlights by Component
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Mode
  • 2.9 Key Market Highlights by Installation Type
  • 2.10 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Continuous Positive Airway Pressure (CPAP)
    • 4.1.2 Bi-level Positive Airway Pressure (BiPAP)
    • 4.1.3 Adaptive Servo-Ventilation
    • 4.1.4 Volume Assured Pressure Support
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Ventilators
    • 4.2.2 Masks
    • 4.2.3 Humidifiers
    • 4.2.4 Accessories
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Chronic Obstructive Pulmonary Disease (COPD)
    • 4.3.2 Asthma
    • 4.3.3 Sleep Apnea
    • 4.3.4 Acute Respiratory Failure
    • 4.3.5 Pneumonia
    • 4.3.6 Cardiogenic Pulmonary Edema
    • 4.3.7 Neuromuscular Disorders
  • 4.4 Market Size & Forecast by End User (2020-2035)
    • 4.4.1 Hospitals
    • 4.4.2 Home Healthcare
    • 4.4.3 Ambulatory Care Centers
    • 4.4.4 Emergency Centers
    • 4.4.5 Long-term Care Facilities
  • 4.5 Market Size & Forecast by Technology (2020-2035)
    • 4.5.1 Mechanical Ventilation
    • 4.5.2 Intelligent Ventilation
    • 4.5.3 Portable Ventilation
    • 4.5.4 Wearable Ventilation
  • 4.6 Market Size & Forecast by Component (2020-2035)
    • 4.6.1 Blower
    • 4.6.2 Tubing
    • 4.6.3 Mask
    • 4.6.4 Humidifier
    • 4.6.5 Filter
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Full Face Masks
    • 4.7.2 Nasal Masks
    • 4.7.3 Nasal Pillow Masks
    • 4.7.4 Oral Masks
  • 4.8 Market Size & Forecast by Mode (2020-2035)
    • 4.8.1 Spontaneous
    • 4.8.2 Timed
    • 4.8.3 Spontaneous/Timed
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 Fixed
    • 4.9.2 Portable
  • 4.10 Market Size & Forecast by Functionality (2020-2035)
    • 4.10.1 Invasive
    • 4.10.2 Noninvasive

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 End User
      • 5.2.1.5 Technology
      • 5.2.1.6 Component
      • 5.2.1.7 Device
      • 5.2.1.8 Mode
      • 5.2.1.9 Installation Type
      • 5.2.1.10 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 End User
      • 5.2.2.5 Technology
      • 5.2.2.6 Component
      • 5.2.2.7 Device
      • 5.2.2.8 Mode
      • 5.2.2.9 Installation Type
      • 5.2.2.10 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 End User
      • 5.2.3.5 Technology
      • 5.2.3.6 Component
      • 5.2.3.7 Device
      • 5.2.3.8 Mode
      • 5.2.3.9 Installation Type
      • 5.2.3.10 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 End User
      • 5.3.1.5 Technology
      • 5.3.1.6 Component
      • 5.3.1.7 Device
      • 5.3.1.8 Mode
      • 5.3.1.9 Installation Type
      • 5.3.1.10 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 End User
      • 5.3.2.5 Technology
      • 5.3.2.6 Component
      • 5.3.2.7 Device
      • 5.3.2.8 Mode
      • 5.3.2.9 Installation Type
      • 5.3.2.10 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 End User
      • 5.3.3.5 Technology
      • 5.3.3.6 Component
      • 5.3.3.7 Device
      • 5.3.3.8 Mode
      • 5.3.3.9 Installation Type
      • 5.3.3.10 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 End User
      • 5.4.1.5 Technology
      • 5.4.1.6 Component
      • 5.4.1.7 Device
      • 5.4.1.8 Mode
      • 5.4.1.9 Installation Type
      • 5.4.1.10 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 End User
      • 5.4.2.5 Technology
      • 5.4.2.6 Component
      • 5.4.2.7 Device
      • 5.4.2.8 Mode
      • 5.4.2.9 Installation Type
      • 5.4.2.10 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 End User
      • 5.4.3.5 Technology
      • 5.4.3.6 Component
      • 5.4.3.7 Device
      • 5.4.3.8 Mode
      • 5.4.3.9 Installation Type
      • 5.4.3.10 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 End User
      • 5.4.4.5 Technology
      • 5.4.4.6 Component
      • 5.4.4.7 Device
      • 5.4.4.8 Mode
      • 5.4.4.9 Installation Type
      • 5.4.4.10 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 End User
      • 5.4.5.5 Technology
      • 5.4.5.6 Component
      • 5.4.5.7 Device
      • 5.4.5.8 Mode
      • 5.4.5.9 Installation Type
      • 5.4.5.10 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 End User
      • 5.4.6.5 Technology
      • 5.4.6.6 Component
      • 5.4.6.7 Device
      • 5.4.6.8 Mode
      • 5.4.6.9 Installation Type
      • 5.4.6.10 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 End User
      • 5.4.7.5 Technology
      • 5.4.7.6 Component
      • 5.4.7.7 Device
      • 5.4.7.8 Mode
      • 5.4.7.9 Installation Type
      • 5.4.7.10 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 End User
      • 5.5.1.5 Technology
      • 5.5.1.6 Component
      • 5.5.1.7 Device
      • 5.5.1.8 Mode
      • 5.5.1.9 Installation Type
      • 5.5.1.10 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 End User
      • 5.5.2.5 Technology
      • 5.5.2.6 Component
      • 5.5.2.7 Device
      • 5.5.2.8 Mode
      • 5.5.2.9 Installation Type
      • 5.5.2.10 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 End User
      • 5.5.3.5 Technology
      • 5.5.3.6 Component
      • 5.5.3.7 Device
      • 5.5.3.8 Mode
      • 5.5.3.9 Installation Type
      • 5.5.3.10 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 End User
      • 5.5.4.5 Technology
      • 5.5.4.6 Component
      • 5.5.4.7 Device
      • 5.5.4.8 Mode
      • 5.5.4.9 Installation Type
      • 5.5.4.10 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 End User
      • 5.5.5.5 Technology
      • 5.5.5.6 Component
      • 5.5.5.7 Device
      • 5.5.5.8 Mode
      • 5.5.5.9 Installation Type
      • 5.5.5.10 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 End User
      • 5.5.6.5 Technology
      • 5.5.6.6 Component
      • 5.5.6.7 Device
      • 5.5.6.8 Mode
      • 5.5.6.9 Installation Type
      • 5.5.6.10 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 End User
      • 5.6.1.5 Technology
      • 5.6.1.6 Component
      • 5.6.1.7 Device
      • 5.6.1.8 Mode
      • 5.6.1.9 Installation Type
      • 5.6.1.10 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 End User
      • 5.6.2.5 Technology
      • 5.6.2.6 Component
      • 5.6.2.7 Device
      • 5.6.2.8 Mode
      • 5.6.2.9 Installation Type
      • 5.6.2.10 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 End User
      • 5.6.3.5 Technology
      • 5.6.3.6 Component
      • 5.6.3.7 Device
      • 5.6.3.8 Mode
      • 5.6.3.9 Installation Type
      • 5.6.3.10 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 End User
      • 5.6.4.5 Technology
      • 5.6.4.6 Component
      • 5.6.4.7 Device
      • 5.6.4.8 Mode
      • 5.6.4.9 Installation Type
      • 5.6.4.10 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 End User
      • 5.6.5.5 Technology
      • 5.6.5.6 Component
      • 5.6.5.7 Device
      • 5.6.5.8 Mode
      • 5.6.5.9 Installation Type
      • 5.6.5.10 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 ResMed
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Fisher Paykel Healthcare
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Vyaire Medical
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BMC Medical
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Drive DeVilbiss Healthcare
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Hamilton Medical
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Air Liquide Medical Systems
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Weinmann Emergency Medical Technology
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Medtronic
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Mindray
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 O-Two Medical Technologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Armstrong Medical
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Seoil Pacific
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Heyer Medical
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Siare Engineering International Group
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us